Pfizer Ltd is the Indian subsidiary of Pfizer Inc, one of the world's leading biopharmaceutical companies. The stock gained traction after company disclosed in an exchange filing that its board has approved a marketing and supply agreement with Mylan Pharmaceuticals. Under this, Pfizer, in collaboration with Mylan Pharma, will market and distribute Ativan and Pacitane in India for five years.